Pfizer 3Q net falls due to generics, higher costs
Pfizer Inc.'s third-quarter profit dropped 19 percent as competition from generic drugs continued to cut sales, while lower operating expenses failed to offset higher taxes and charges.
Oct 29, 2013
0
0